Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77,331,078
-
Total 13F shares
-
5,377,405
-
Share change
-
-332,431
-
Total reported value
-
$32,047,000
-
Price per share
-
$5.90
-
Number of holders
-
20
-
Value change
-
-$2,511,469
-
Number of buys
-
4
-
Number of sells
-
10
Institutional Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE) as of Q2 2016
As of 30 Jun 2016 Xenon Pharmaceuticals Inc. - Common Stock (XENE) had 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,377,405 shares of stock of the company.
Largest 10 holders included BVF INC/IL, Capital World Investors, Invesco Private Capital, Inc., PERCEPTIVE ADVISORS LLC, Opaleye Management Inc., ROYAL BANK OF CANADA, Point72 Asset Management, L.P., DAFNA Capital Management LLC, Novo A/S, and State of New Jersey Common Pension Fund D.
This table shows 20 institutional shareholders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.